Reduced levels of growth hormone, insulin-like growth factor-I and binding protein-3 in patients with shunted hydrocephalus

Archives of Disease in Childhood

Volumn 77, Issue 1, 1997, Pages 32-37

  Löppönen, Tuija ^a   Saukkonen, Anna Liisa ^b   Serlo, Willy ^b   Tapanainen, Päivi ^a   Ruokonen, Aimo ^b   Knip, Mikael ^a  

^a UNIVERSITY OF OULU   (Finland)

^b Department of Paediatrics ^*

Author keywords

Growth hormone; Hydrocephalus; Insulin like growth factor I and binding protein 3 in shunted hydrocephalus

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; ADULT; ARTICLE; CEREBROSPINAL FLUID SHUNTING; CHILD; CHILD GROWTH; CONTROLLED STUDY; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH REGULATION; HUMAN; HYDROCEPHALUS; MAJOR CLINICAL STUDY; MALE; PREPUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0030833679     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.77.1.32     Document Type: Article

References (43)

1. Greene SA, Frank M, Zachmann M, Prader A. Growth and sexual development in children with meningomyelocele. EurJ Pediatr 1985;144:146-8.
2. Rosenblum MF, Fintgold DN, Charney EB. Assessment of stature of children with meningomyelocele, and usefulness of arm-span measurement. Dev Med Child Neural 1983;25: 338-42.
3. Kalen V, Harding C. Skeletal maturity in myelodysplasia. Dev Med CkOd Neural 1994;36:528-32.
4. Kaiser G, Ruedeberg A, Arnold M. Endocrinological disorders in shunted hydrocephalus. Z Kinderchir 1989;44 (suppl l):16-7.
5. Löppönen T, Saukkonen A-L, Serlo W, Lanning P, Knip M. Slow prepubertal linear growth but early pubertal growth spurt in patients with shunted hydrocephalus. Pediatrics 1995;95:917-23.
6. Rotenstein D, Reigel DH. Growth hormone treatment of children with neural tube defects: results from 6 months to 6 years. J Pediatr 1996;128:184-9.
7. Rotenstein D, Breen TJ. Growth hormone treatment of children with myelomeningocele. J Pediarr 1996;128:S2831.
8. Hammock MK, Milhorat TH, August G, McKay D. Growth hormone (hGH) levels in patients with hydrocephalus. Z Kinderchir 1977;22:413-8.
9. Leveratto L, Picco P, Cama A, et al. Insulin-like growth factor I (IFG-I) in children with neural tube closure defects: a preliminary report. Eur J Pediatr Surg 1993;3:19-20.
10. Amacher AL, Wellington J. Infantile hydrocephalus: longterm results of surgical therapy. Child's Brain 1984;11:21729.
11. Serlo W. Shunt treatment of hydrocephalus in children [dissertation]. Acta Univmitatis Ouluensis 1985; series D, medica 130.
12. Saukkonen A-L. Childhood hydrocephalus. Electroencephalography, epilepsy and slit ventricle syndrome [dissertation]. Acta Universitatis Ouluensis 1989; series D, medica 185.
13. Pääkkö E, Löppönen T, Saukkonen A-L, et ai. Information value of magnetic resonance imaging in shunted hydrocephalus. Arch Dis Child 1994;70:530-5.
14. Sorva R, Perheentupa J, Tolppanen EM. New format for a growth chart. ActaPaediairScandl984;13:527-9.
15. Dahlstrom S, Viikari J, Akerblom HK, et al. Atherosclerosis precursors in Finnish children and adolescents. II. Height, weight, body mass index, and skinfolds, and their correlations to metabolic variables. Acta Paediatr Scand 1985; suppl 318:65-78.
16. Owen GM. Measurement, recording and assessment of skinfold thickness in childhood and adolescence: report of a small meeting. Am J Clin Nun- 1982;3S:629-38.
17. Parizkova J. Total body fat and skinfold thickness in children. Metabolism 1961;10:794-807.
18. Keys A, Brozek J. Body fat in adult man. Physiol Rev 1953; 33:245-51.
19. Mueller WH, Marbella A, Harrist RB, et a!. Body circumferences as alternatives to skinfold measures of body fat distribution in children. Ann Hum Biol 1989;16:495-506.
20. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, and stages of puberty./IrcA Dis Chad 1976;51:170-82.
21. Tapanainen P, Knip M. Evaluation of growth hormone secretion and treatment. Ann Med 1992;24:237-47.
22. Furlanetto R. Insulin-like growth factor measurements in evaluation of growth hormone secretion. Horm Res 1990;33:25-30.
23. Juul A, Bang P, Hertel N T, et a!. Serum insulin-like growth factor-I in 1030 healthy children, adolescents and adults: relation to age, sex, stage of puberty, testicular size and body mass index. J Clin Endocrinol Metab 1994;78:744-752.
24. Rogol AD. Growth and growth hormone secretion at puberty: the role of gonadal steroid hormones. Acta Paediarr 992;3S3:15-20.
25. Baxter RC, Martin JL. Structure of the MR 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labelling. Proc Nail Acad Sei U S A 1989;86:6898902.
26. Blum WF, Ranke MB, Kietzmann JK, Gauggel E, Zeisel HJ, Bierich JR. A specific radioimmunoassay for the growth hormone (GH)-dependent somatpmedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 1990;70:1504-12.
27. Blum WF, Albertson-Wikland K, Rosenberg S, Ranke MB. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab 1993;76:16106.
28. Philips M, Chalew SA, Koyvarski AA, Stene MA. Plasma IGFBP-3 and its relationship with quantitative growth hormone secretion in short children. Clin Endocrinol (Oxf) 1993;39:427-32.
29. Cohen P, Rosenfeld RG. Physiologic and clinical relevance of the insulin-like growth factor binding proteins. Curr Opin Pediatr 1994;6:462-7.
30. Löppönen T, Pääkkö E, Laitinen J, et al. Pituitary size and function in children and adolescents with shunted hydrocephalus. Clin Endocrinol (Oxf) 1997;47 (in press).
31. Albertsson-Wikland K, Rpsberg S. Analyses of 24-hour growth hormone profiles in children: relation to growth. J Clin Endocrinol Metab 1988;67:493-500.
32. Löppönen T, Saukkonen A-L, Serlo W, Tapanainen P, Ruokonen A, Knip M. Accelerated pubertal development in patients with shunted hydrocephalus. Arch Dis Child 1996;7S:490-6.
33. Sklar CA, Rothenberg S, Blumberg D, et al. Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulinlike growth factor-I, and prolactin secretion. JCm Endocrim Afail991;73:734-8.
34. Williams T, Berelowitz M, Joffe SN, et al. Impaired growth hormone responses to growth hormone-releasing factor in obesity. NEnglJMed 1984;311:1403-7.
35. Kamp GA, Manasco PK, Barnes KM, et al. Low growth hormone levels are related to increased body mass index and dp not reflect impaired growth in luteinizing hormonereleasing hormone agonist-treated children with precocious puberty. J Clin Endocrinol Metab 1991 ;72:301 -7.
36. Vanderschueren-Lodeweyckx M. The effect of simple obesity on growth and growth hormone. Horm Res 1993;40:2330.
37. Loche S, Cappa M, Borelli P, et al. Reduced growth hormone response to growth hormone-releasing hormone in children with simple obesity: evidence for somatomedin-C mediated inhibition. Clin Endocrinol fO 1987;27:145-53.
38. Caufiez A, Golstein J, Lebrun P, et al. Relations between immunoreactive somatomedin C, insulin and T3 patterns during fasting in obese subjects. Clin Endocrinol (Oxf) 1984;20:65-70.
39. Minuto F, Barreca A, Del Monte P, et al. Spontaneous growth hormone and somatomedin-C/insuIin-like growth factor-I secretion in obese subjects during puberty. JEndocrinollnvest 1988;ll:489-95.
40. Wilson DM, Killen JD, Hammer LD, et al. Insulin-like growth factor-I as a reflection of body composition, nutrition, and puberty in sixth and seventh grade girls. J Clin Endocrinol Metab 1991;73:907-12_.
41. Isojârvi JIT, Pakarinen AJ, Myllylä W. A prospective study of serum sex hormones during carbamazepine therapy. Epilepsy Res 1991;9:139-44.
42. Isojârvi JIT, Laatikainen T, Pakarinen A, Juntunen KTS, Myllylä W. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993;329:1383-8.
43. Isojârvi JIT, Laatikainen TJ, Knip M, Pakarinen AJ, Juntunen KTS, Myllylä V. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neural 1996;39:579-84.